You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Two Degrees of Freedom of EMG-Based Proportional Control in a Hand-Wrist Prosthes

    SBC: LIBERATING TECHNOLOGIES INC            Topic: NICHD

    SUMMARY: Upper limb amputation is experienced by approximately 18,496 persons annually in the U.S., with most of these amputations transradial or more distal. Existing commercial prosthesis devices only allow such users to control one device at a time (e.g., choose between hand actuation and wrist actuation), commonly via EMG-based inputs. Users then switch between devices sequentially. It is repo ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Bimanual Robotic Rehabilitation System with Variable Interaction Modes

    SBC: BARRETT TECHNOLOGY, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): This Small Business Innovation Research (SBIR) Phase I project proposes a bimanual robotic rehabilitation system, named BiArm , for stroke survivors who experience hemiparesis - weakness on one side of the body. The system is comprised of two special three-dimensional robotic arms designed to interact through forces with people over large reachable workspaces, ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. High-intensity, collapsible phototherapy device for neonatal jaundice for home use

    SBC: Little Sparrows Technologies LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Approximately 8% of all newborns risk permanent neurotoxic brain injury due severe neonatal jaundice (SNJ). This condition, generally occurring in the first two weeks of life, is almost always cured with high- intensityblue light phototherapy In the United States, most phototherapy is delivered in a neonatal intensive care unit (NICU) or inpatient nursery becau ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. An Adaptive Prosthetic Terminal Device

    SBC: EMPIRE ROBOTICS, INC.            Topic: NICHD

    DESCRIPTION (provided by applicant): Empire Robotics, Inc., in collaboration with Liberating Technologies, Inc., is proposing to develop an adaptive prosthetic gripper enabled by the jamming of granular media. Empire Robotics has previously demonstratedthe utility of the gripper's core technology-in which granular media contained in a flexible, impermeable membrane can transition between s ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Function First: An Online Assessment and Intervention Tool to Reduce Runaways

    SBC: C4 Innovations, LLC            Topic: NICHD

    ? DESCRIPTION (provided by applicant): An estimated 1.6 to 2.8 million youth run away or are evicted by their caregivers in the US each year. Youth in foster care are twice as likely to exhibi runaway behaviors as youth in the general population. Theyfrequently face dangerous situations, engage in high-risk behaviors, and have problems that include drug and alcohol abuse, severe emotional and ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Digital PCR in a microplate format: high-throughput, precise DNA quantification

    SBC: FORMULATRIX, INC.            Topic: NHGRI

    DESCRIPTION (provided by applicant): Quantitative PCR (qPCR) is the current industry standard for quantification of DNA samples, and is used commonly in diagnostics and research. Digital PCR (dPCR) presents numerous advantages over qPCR such as increased precision and sensitivity and absolute quantification without comparison to standards. However, current digital PCR systems require complex workf ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. ACOUSTOPHORETIC TRANSFUSION TO REDUCE EMBOLIZATION IN CARDIOPULMONARY BYPASS

    SBC: Flodesign Sonics, Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Retransfusion of a patient's shed blood during cardiopulmonary bypass is attractive since it reduces the need for allogeneic transfusion, minimizes cost, and decreases transfusion related morbidity. Heterologous transfusions are linked to increased long term mortality after cardiac surgery. However, brain damage after cardiac surgery with retransfusion of ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. A Bioactive Nanofibrous Sewing Cuff for Treatment of Cardiac Valvular Disease

    SBC: BIOSURFACES INC            Topic: NHLBI

    PROJECT SUMMARY Cardiac valve repair or replacement is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvular dysfunction, thereby impacting cardiac output. Both procedures require the use of a woven or knitted polyester material with an internal reinforcement (Teflon, silicone or metal) to either stabilize the native valve (annuloplasty r ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Depletion of iNKT Cells in the Treatment of Hypoxic Crises in Sickle Cell Mice

    SBC: NKT THERAPEUTICS, INC.            Topic: NHLBI

    There is a central role for iNKT cells in mediating inflammatory responses in sickle cell disease. NKT Therapeutics has developed a humanized monoclonal antibody (NKTT120) that can specifically mediate iNKT cell depletion by antibody and complement directed cellular cytotoxicity. We are currently engaged in a safety/PK Phase 1 study in stable sickle cell disease patients. Although the use of speci ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease

    SBC: MyoSyntax Corporation            Topic: NHLBI

    DESCRIPTION (provided by applicant): Sickle cell disease is a major clinical problem in the US, France, the United Kingdom, Brazil, and in Africa, India and the Middle East. A recent study shows that the annual cost of medical care in the US for people whosuffer from sickle cell disease exceeds 1.1 billion. Sickle hemoglobin (HbS) polymerization drives the pathophysiology of this disease. Fetal h ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government